Insider filing
Traded Nov 11 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 13, 2026 · Filed Nov 13, 2026
The CEO of Altimmune paid $50K out of pocket for Altimmune shares. 2 other people at Altimmune bought some too, in the same month. It was the first purchase in over a year.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$49,694
Shares × reported transaction price
$25K–$100K
+49.1%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
None in 20 months of history
Confirmed open-market purchases by the same insider in the available history
3 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
1 day after results of Nov 12, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $1.65 on Nov 13, 2026, within 3% of its 52-week low, after a 40% drop over the previous 30 trading days
52-week range $1.61 (Nov 12, 2026) to $6.18 (Jan 27, 2026), 1% of the way up, from 250 adjusted closes. 30 trading days earlier: $2.74 on Oct 2, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
3 ALT insiders bought within the same week. That happened 5 times before in filings since 2007, most recently Mar 2023. The first open-market purchase by any ALT insider since Mar 2025. Jerome Benedict Durso's first open-market purchase of ALT in filings since 2007
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
Insider filing
Traded Nov 11 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Insider filing
Traded Nov 11 · filed 2 days later
Routine share withholding; mechanical by default.
Insider filing
Traded Nov 11 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.